1. Editorial

   • P. D. Delmas
   • J. D. Ringe

   EditorialNotes 19 March 2003 Pages: 1 - 1

2. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis

   • Ego Seeman

   Review Article 19 March 2003 Pages: 2 - 8

   

3. Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate

   • P. J. Marie

   Review Article 18 March 2003 Pages: 9 - 12

   

4. Bone strength and its determinants

   • P. Ammann
   • R. Rizzoli

   Review Article 19 March 2003 Pages: 13 - 18

   

5. The mineralization of bone tissue: a forgotten dimension in osteoporosis research

   • G. Boivin
   • P. J. Meunier

   Review Article 18 March 2003 Pages: 19 - 24

   

6. Is the calcium receptor a molecular target for the actions of strontium on bone?

   • Edward M. Brown

   Review Article 12 March 2003 Pages: 25 - 34

7. Bone matrix proteins: their function, regulation, and relationship to osteoporosis

   • Marian F. Young

   Review Article 12 March 2003 Pages: 35 - 42

8. Assessment of prevalent and incident vertebral fractures in osteoporosis research

   • H. K. Genant
   • M. Jergas

   Review Article 12 March 2003 Pages: 43 - 55

   

9. Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies

   • J. Y. Reginster
   • P. J. Meunier

   Review Article 12 March 2003 Pages: 56 - 65

   

10. Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis

    • P. J. Meunier
    • J. Y. Reginster

    Original Article 12 March 2003 Pages: 66 - 76